skip to main content

Raising awareness online in the fight against cancer

We worked with biotech firm Iksuda to help secure £6m of funding in the battle to cure cancer.

Who are Iksuda?

Iksuda are helping to cure cancer. 

Their revolutionary technology targets tumours that have limited treatment options and that are associated with high relapse rates.

Our partnership

Part of IP Group, Iksuda embarked on a high awareness and investor relations campaign to secure next round funding and continue their research and development.

To achieve their goals, we partnered with them to redefine their go-to-market strategy, including a rename, rebranding and external facing communication material.

The exceptional™ results

With our help, Iksuda achieved its next round of funding. 

This has allowed them to continue the development of antibody based cancer treatments, including developing treatments for cancers which are usually resistant or refractory to current therapies.

The exceptional™ impact

“The end result was beyond our expectations and very well received by the market. We’ve had increased awareness about our business, which led to licensing opportunities and more growth.”

David Simpson – CEO, Iksuda